Leukocyte- and Platelet-Rich Fibrin Versus Connective Tissue Graft for a Coronally Advanced Flap in the Treatment of Miller Class I and II Localized Gingival Recessions: A Randomized Controlled Clinical Trial
Author(s) -
Catherine Andrade,
Antonio José Ortiz Ruiz,
David Rosenberg,
Marc Quirynen,
Nelson Pinto Carrasco
Publication year - 2021
Publication title -
the international journal of periodontics and restorative dentistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.7
H-Index - 82
eISSN - 1945-3388
pISSN - 0198-7569
DOI - 10.11607/prd.5093
Subject(s) - medicine , gingival recession , platelet rich fibrin , fibrin , randomized controlled trial , connective tissue , dentistry , clinical trial , surgery , pathology , immunology
The aim of the present study was to compare leukocyte- and platelet-rich fibrin (L-PRF) membranes with a connective tissue graft (CTG) in combination with a coronally advanced flap (CAF) in the treatment of Miller Class I or II localized gingival recessions. A randomized controlled clinical trial with 17 recessions in each group was initiated; the control group received treatment with CAF+CTG, and the test group received CAF+L-PRF. The following variables were measured before treatment and after 1, 3, and 6 months: gingival recession depth (RD), gingival recession width (RW), gingival thickness (GT), probing depth (PD), clinical attachment level (CAL), and keratinized tissue height (KTH). Also, the root coverage percentage (RC), the pain score, postoperative complications, and the root coverage esthetic score (RES) were recorded after surgery. Both treatments presented significant improvements in the RD, RW, and CAL at 1, 3, and 6 months. CTG achieved a significantly higher RC at 1, 3, and 6 months and a significantly higher RES score at 6 months. L-PRF presented a significantly lower pain score and less postoperative complications. Both strategies were effective for the treatment of localized gingival recessions. The CTG obtained higher RC and esthetic results, and L-PRF had less pain and postsurgical complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom